Tetracycline hydrochloride (TCH)-loaded drug carrier based on PLA:PCL nanofibre mats: experimental characterisation and release kinetics modelling
Source abstract
Abstract
The experimental characterisation of electrospun poly(lactic acid) (PLA):poly(e-caprolactone) (PCL) as drug carriers, at five blend ratios from 1:0, 3:1, 1:1, 1:3 and 0:1, was holistically investigated in terms of their morphological structures, crystallinity levels and thermal properties. A widely used antibiotic tetracycline hydrochloride (TCH) was loaded to prepared fibrous mats at TCH concentrations of 1 and 5 wt%. The additional TCH into PLA:PCL better facilitates the reduction of fibre diameter than polymer blends. Increasing the TCH concentration from 1 to 5 wt% was found to result in only a modest decrease in the crystallinity level, but a significant increase in the crystallisation temperature (T c) for PLA within PLA:PCL blends. The infrared spectra of fibre mats confirm the successful TCH encapsulation into fibrous networks. The first order and Zeng models for drug release kinetics were in better agreement with experimental release data, indicating the release acceleration of TCH with increasing its concentration. In a typical case of PLA:PCL (1:1) loaded with 5 wt% TCH, the fibre mats apparently demonstrate more wrinkled and floppy structures and increased fibre diameters and decreased inter-fibrous spaces after 7-day in vitro fibre degradation, as opposed to those obtained after 3-h degradation.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · biodegradable polymer synthesis and properties · Advanced Sensor and Energy Harvesting Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (58)
Show source-provided references
1. Chowdhury M, Stylios G (2011) Process optimization and alignment of PVA/FeCl3 nano composite fibres by electrospinning. J Mater Sci 46:3378–3386. doi: 10.1007/s10853-010-5226-510.1007/s10853-010-5226-5 ↗
2. Dong Y, Chaudhary D, Haroosh H, Bickford T (2011) Development and characterisation of novel electrospun polylactic acid/tubular clay nanocomposites. J Mater Sci 46:6148–6153. doi: 10.1007/s10853-011-5605-610.1007/s10853-011-5605-6 ↗
3. Haroosh HJ, Chaudhary DS, Dong Y (2012) Electrospun PLA/PCL fibers with tubular nanoclay: morphological and structural analysis. J Appl Polym Sci 124:3930–393910.1002/app.35448 ↗
4. Haroosh HJ, Dong Y, Chaudhary DS, Ingram GD, Yusa S (2013) Electrospun PLA:PCL composites embedded with unmodified and 3-aminopropyltriethoxysilane (ASP) modified halloysite nanotubes (HNT). Appl Phys A Mater Sci Process 110:433–44210.1007/s00339-012-7233-7 ↗
5. Dong Y, Bickford T, Haroosh HJ, Lau KT, Takagi H (2013) Multi-response analysis in the material characterisation of electrospun poly (lactic acid)/halloysite nanotube composite fibres based on Taguchi design of experiments: fibre diameter, non-intercalation and nucleation effects. Appl Phys A Mater Sci Process 112:747–75710.1007/s00339-013-7789-x ↗
6. Azman NN, Siddiqui S, Haroosh H, Albertran H, Johannessen B, Dong Y, Low IM (2013) Characteristics of X-ray attenuation in electrospun bismuth oxide/poly-lactic acid nanofibre mats. J Synchroton Radiat 20:741–74810.1107/S0909049513017871 ↗
7. Albetran H, Haroosh H, Dong Y, Prida VM, O’Connor BH, Low IM (2014) Phase transformations and crystallization kinetics in electrospun TiO2 nanofibers in air and argon atmospheres. Appl Phys A Mater Sci Process. doi: 10.1007/s00339-014-8246-1
8. Dong Y, Mosaval T, Haroosh HJ, Umer R, Takagi H, Lau KT (2014) The potential use of electrospun PLA nanofibres as alternative reinforcements in an epoxy composite system. J Polym Sci B 52:618–62310.1002/polb.23467 ↗
9. Kim K, Luu YK, Chang C, Fang D, Hsiao BS, Chu B, Hadjiargyrou M (2004) Incorporation and controlled release of a hydrophilic antibiotic using poly(lactide-co-glycolide)-based electrospun nanofibrous scaffolds. J Control Release 98:47–5610.1016/j.jconrel.2004.04.009 ↗
10. Haroosh HJ, Dong Y, Ingram GD (2013) Synthesis, morphological structures and material characterization of electrospun PLA:PCL/magnetic nanoparticle composites for drug delivery. J Polym Sci B 51:1607–161710.1002/polb.23374 ↗
11. Nair LS, Bhattacharyya S, Laurencin CT (2004) Development of novel tissue engineering scaffolds via electrospinning. Expert Opin Biol Ther 4:659–66810.1517/14712598.4.5.659 ↗
12. Verreck G, Chun I, Rosenblatt J, Peeters J, Dijck AV, Mensch J, Noppe M, Brewster ME (2003) Incorporation of drugs in an amorphous state into electrospun nanofibers composed of a water-insoluble, nonbiodegradable polymer. J Control Release 92:349–36010.1016/S0168-3659(03)00342-0 ↗
13. Thakur RA, Florek CA, Kohn J, Michniak BB (2008) Electrospun nanofibrous polymeric scaffold with targeted drug release profiles for potential application as wound dressing. Int J Pharm 364:87–9310.1016/j.ijpharm.2008.07.033 ↗
14. Meng ZX, Zheng W, Li L, Zheng YF (2011) Fabrication, characterization and in vitro drug release behavior of electrospun PLGA/chitosan nanofibrous scaffold. Mater Chem Phys 125:606–61110.1016/j.matchemphys.2010.10.010 ↗
15. Katti DS, Robinson KW, Ko FK, Laurencin CT (2004) Bioresorbable nanofiber-based systems for wound healing and drug delivery: optimization of fabrication parameters. J Biomed Mater Res, Part B 70B:286–29610.1002/jbm.b.30041 ↗
16. Luong-Van E, Grøndahl L, Chua KN, Leong KW, Nurcombe V, Cool SM (2006) Controlled release of heparin from poly(ε-caprolactone) electrospun fibers. Biomaterials 27:2042–205010.1016/j.biomaterials.2005.10.028 ↗
17. Kenawy E, Abdel-Hay F, El-Newehy M, Wnek G (2009) Processing of polymer nanofibers through electrospinning as drug delivery systems. Mater Chem Phys 113:296–30210.1016/j.matchemphys.2008.07.081 ↗
18. Taepaiboon P, Rungsardthong U, Supaphol P (2006) Drug-loaded electrospun mats of poly(vinyl alcohol) fibres and their release characteristics of four model drugs. Nanotechnology 17:231710.1088/0957-4484/17/9/041 ↗
19. Deng XL, Sui G, Zhao ML, Chen GQ, Yang XP (2007) Poly(l-lactic acid)/hydroxyapatite hybrid nanofibrous scaffolds prepared by electrospinning. J Biomater Sci Polym Ed 18:117–13010.1163/156856207779146123 ↗
20. Lim LT, Auras R, Rubino M (2008) Processing technologies for poly(lactic acid). Prog Polym Sci 33:820–85210.1016/j.progpolymsci.2008.05.004 ↗
21. Touny A, Lawrence J, Jones A, Bhaduri S (2010) Effect of electrospinning parameters on the characterization of PLA/HNT nanocomposite fibers. J Mater Res 25:857–86510.1557/JMR.2010.0122 ↗
22. Xu X, Zhong W, Zhou S, Trajtman A, Alfa M (2010) Electrospun PEG–PLA nanofibrous membrane for sustained release of hydrophilic antibiotics. J Appl Polym Sci 118:588–59510.1002/app.32415 ↗
23. Lee K, Kim H, Khil M, Ra Y, Lee D (2003) Characterization of nano-structured poly(ε-caprolactone) nonwoven mats via electrospinning. Polymer 44:1287–129410.1016/S0032-3861(02)00820-0 ↗
24. Huang Z, He C, Yang A, Zhang Y, Han X, Yin J, Wu Q (2006) Encapsulating drugs in biodegradable ultrafine fibers through co-axial electrospinning. J Biomed Mater Res A 77:169–17910.1002/jbm.a.30564 ↗
25. Picciani PHS, Medeiros ES, Pan Z, Orts WJ, Mattoso LHC, Soares BG (2009) Development of conducting polyaniline/poly(lactic acid) nanofibers by electrospinning. J Appl Polym Sci 112:744–75210.1002/app.29447 ↗
26. Islam M (2010) Fabrication and characterization of poly(vinyl alcohol)/alginate blend nanofibers by electrospinning method. Colloids Surf A Physicochem Eng Asp 366:135–14010.1016/j.colsurfa.2010.05.038 ↗
27. Dhandayuthapani B, Krishnan U, Sethuraman S (2010) Fabrication and characterization of chitosan gelatin blend nanofibers for skin tissue engineering. J Biomed Mater Res B 94:264–27210.1002/jbm.b.31651 ↗
28. Xie Z, Buschle-Diller G (2010) Electrospun poly(d,l-lactide) fibers for drug delivery: the influence of cosolvent and the mechanism of drug release. J Appl Polym Sci 115:1–810.1002/app.31026 ↗
29. Alexander LE (1969) X-ray diffraction methods in polymer science. Wiley, New York
30. Ning N, Yin Q, Luo F, Zhang Q, Du R, Fu Q (2007) Crystallization behavior and mechanical properties of polypropylene/halloysite composites. Polymer 48:7374–738410.1016/j.polymer.2007.10.005 ↗
31. Chittur KK (1998) FTIR/ATR for protein adsorption to biomaterial surfaces. Biomaterials 19:357–36910.1016/S0142-9612(97)00223-8 ↗
32. Cai X, Luan Y, Dong Q, Shao W, Li Z, Zhao Z (2011) Sustained release of 5-fluorouracil by incorporation into sodium carboxymethylcellulose sub-micron fibers. Int J Pharm 419:240–24610.1016/j.ijpharm.2011.07.008 ↗
33. Das RK, Kasoju N, Bora U (2010) Encapsulation of curcumin in alginate–chitosan–pluronic composite nanoparticles for delivery to cancer cells. Nanomed Nanotechnol Biol Med 6:153–16010.1016/j.nano.2009.05.009 ↗
34. Zeng L, An L, Wu X (2011) Modeling drug–carrier interaction in the drug release from nanocarriers. J Drug Deliv. doi: 10.1155/2011/370308
35. Ritger PL, Peppas NA (1987) A simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release 5:23–3610.1016/0168-3659(87)90034-4 ↗
36. Varelas CG, Dixon DG, Steiner CA (1995) Zero-order release from biphasic polymer hydrogels. J Control Release 34:185–19210.1016/0168-3659(94)00085-9 ↗
37. Kalam MA, Humanyun M, Parvez N, Yada S, Garg A, Amin S, Sultana Y, Ali A (2007) Release kinetics of modified pharmaceutical dosage forms: a review. Cont J Pharm Sci 1:30–35
38. Gibaldi M, Feldman S (1967) Establishment of sink conditions in dissolution rate determinations. Theoretical considerations and application to nondisintegrating dosage forms. J Pharm Sci 56:1238–124210.1002/jps.2600561005 ↗
39. Wagner JG (1969) Interpretation of percent dissolved–time plots derived from in vitro testing of conventional tablets and capsules. J Pharm Sci 58:1253–125710.1002/jps.2600581021 ↗
40. Li P, Dai YN, Zhang JP, Wang AQ, Wei Q (2008) Chitosan–alginate nanoparticles as a novel drug delivery system for nifedipine. Int J Biomed Sci 4:221–22810.59566/IJBS.2008.4221 ↗
41. Higuchi T (1961) Rate of release of medicaments from ointment bases containing drugs in suspension. J Pharm Sci 50:874–87510.1002/jps.2600501018 ↗
42. Higuchi T (1963) Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 52:1145–114910.1002/jps.2600521210 ↗
43. Desai SJ, Simonelli AP, Higuchi WI (1965) Investigation of factors influencing release of solid drug dispersed in inert matrices. J Pharm Sci 54:1459–146410.1002/jps.2600541012 ↗
44. Desai SJ, Singh P, Simonelli AP, Higuchi WI (1966) Investigation of factors influencing release of solid drug dispersed in inert matrices II: quantitation of procedures. J Pharm Sci 55:1224–122910.1002/jps.2600551112 ↗
45. Lapidus H, Lordi NG (1966) Some factors affecting the release of a water-soluble drug from a compressed hydrophilic matrix. J Pharm Sci 55:840–84310.1002/jps.2600550818 ↗
46. Lapidus H, Lordi NG (1968) Drug release from compress hydrophilic matrices. J Pharm Sci 57:1292–130110.1002/jps.2600570803 ↗
47. Siepmann J, Peppas NA (2001) Modeling of drug release from delivery systems based on hydroxypropylmethylcellulose (HPMC). Adv Drug Deliv Rev 48:139–15710.1016/S0169-409X(01)00112-0 ↗
48. Ritger PL, Peppas NA (1987) A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Release 5:37–4210.1016/0168-3659(87)90035-6 ↗
49. Spasova M, Stoilova O, Manolova N, Rashkov I, Altankov G (2007) Preparation of PLLA/PEG nanofibers by electrospinning and potential applications. J Bioact Compat Polym 22:62–7610.1177/0883911506073570 ↗
50. Lee G, Song J, Yoon K (2010) Controlled wall thickness and porosity of polymeric hollow nanofibers by coaxial electrospinning. Macromol Res 18:571–57610.1007/s13233-010-0607-9 ↗
51. Saraf A, Lozier G, Haesslein A, Kasper FK, Raphael RM, Baggett LS, Mikos AG (2009) Fabrication of nonwoven coaxial fiber meshes by electrospinning. Tissue Eng Part C Methods 15:333–34410.1089/ten.tec.2008.0422 ↗
52. Puppi D, Piras A, Detta N, Dinucci D, Chiellini F (2010) Poly(lactic-co-glycolic acid) electrospun fibrous meshes for the controlled release of retinoic acid. Acta Biomater 6:1258–126810.1016/j.actbio.2009.08.015 ↗
53. Sinha VR, Bansal K, Kaushik R, Kumria R, Trehan A (2004) Poly-ε-caprolactone microspheres and nanospheres: an overview. Int J Pharm 278:1–2310.1016/j.ijpharm.2004.01.044 ↗
54. Gan ZH, Liang QZ, Zhang J, Jing XB (1997) Enzymatic degradation of poly(ε-caprolactone) film in phosphate buffer solution containing lipases. Polym Degrad Stab 56:209–21310.1016/S0141-3910(96)00208-X ↗
55. Pastorino L, Piolic F, Zillid M, Convertid A, Nicolini C (2004) Lipase-catalyzed degradation of poly(ε-caprolactone). Enzyme Microb Technol 35:321–32610.1016/j.enzmictec.2004.05.005 ↗
56. Huang MH, Li S, Vert M (2004) Synthesis and degradation of PLA–PCL–PLA triblock copolymer prepared by successive polymerization of ε-caprolactone and dl-lactide. Polymer 45:8675–868110.1016/j.polymer.2004.10.054 ↗
57. Stefani M, Coudane J, Vert M (2006) In vitro ageing and degradation of PEG–PLA diblock copolymer-based nanoparticles. Polym Degrad Stab 91:2554–255910.1016/j.polymdegradstab.2006.05.009 ↗
58. Maquet V, Boccaccini AR, Pravata L, Notingher I, Jérôme R (2004) Porous poly(α-hydroxyacid)/Bioglass® composite scaffolds for bone tissue engineering. I: Preparation and in vitro characterisation. Biomaterials 25:4185–419410.1016/j.biomaterials.2003.10.082 ↗